Skip to main content
. 2023 Jan 30;39(Suppl 1):3–164. doi: 10.1002/joa3.12808
Timing reduced pre‐operative HRV 7 days after operation p (CI) 3 months after operation p (CI) 6 months after operation p (CI)
AF (+) (n = 16) AF (−) (n = 101) AF (+) (n = 16) AF (−) (n = 100) AF (+) (n = 20) AF (−) (n = 96)

ASDNN

(n,%)

< 30 ms

5

(22.70)

17

(77.30)

> 0.05

(0.69–7.29)

8 (38.10) 13 (61.90)

<0.05*

(2.14 – 20.92)

7 (33.30) 14 (66.70)

< 0.05*

(1.0–9.28)

≥ 30 ms

11

(11.60)

84

(88.40)

8 (8.40) 87 (91.60) 13 (13.70) 82 (86.30)

rMSSD

(n,%)

< 15 ms

7

(41.20)

10

(58.80)

<0.05*

(2.16–23.12)

5 (31.20) 11 (68.80)

<0.05*

(1.07–12.56)

4 (25.00) 12 (75.00)

>0.05

(0.50–6.11)

≥ 15 ms

9

(9.00)

91

(91.00)

11 (11.00) 89 (89.00) 16 (16.00) 84 (84.00)

pNN 50

(n,%)

< 0.75% 7 (28.00) 18 (72.00)

<0.05*

(1.18–10.89)

5 (20.80) 19 (79.20)

> 0.05

0.60–6.23

6 (25.00) 18 (75.00)

>0.05

(0.62–5.49)

≥ 0.75%

9

(9.80)

83 (90.2) 11 (12.00) 81 (88.00) 14 (15.20) 78 (84.80)

SDNN

(n,%)

< 50 ms 4 (44.40) 5 (55.60)

<0.05*

(1.50–27.15)

6 (75.00) 2 (25.00)

< 0.01*

(5.22 – 16.4)

4 (50.00) 4 (50.00)

< 0.05*

(1.30–25.36)

≥ 50 ms 12 (11.1) 96 (88.9) 10 (9.30) 98 (90.70) 16 (14.80) 92 (85.20)

SDNN

(n,%)

≥ 93 ms 11 (20.8) 42 (79.2)

<0.05*

(1.0–9.56)

10 (19.2) 42 (80.8)

>0.05

(0.77–6.82)

12 (23.1) 40 (76.9)

>0.05

(0.78–5.60)

< 93 ms

5

(7.8)

59 (92.2)

6

(9.4)

58 (90.6)

8

(12.5)

56 (87.5)

SDANN

(n,%)

< 40 ms 3 (60.00) 2 (40.00)

<0.05*

(1.74–74.88)

2 (40.00) 3 (60.00)

>0.05

(0.70–30.11)

2 (40.00) 3 (60.00)

>0.05

(0.53–2210)

≥ 40 ms 13 (11.60) 99 (88.40) 14 (12.60) 97 (87.40) 18 (16.20) 93 (83.80)

Entries are numbers of patients. p‐values are nominal. CI: confidence of interval. The cut‐off for each index of reduced HRV time domain as recommended. * Statistically significant difference.